References - Signal Processing in MRS with Biomedical Applications - page 435

[406] Bouchardy, C., Fioretta, G., Rapiti, E., Verkooijen, H., Rapin, C.,
Schmidlin, F., Miralbell, R., and Zanetti, R., Recent trends in prostate
cancer mortality show a continuous decrease in several countries, Int.
J. Cancer, 123, 421 - 429, 2008.
[407] Bosetti, C., Bertuccio, P., Levi, F., Lucchini, F., Negri, E., and La
Vecchia, C., Cancer mortality in the European Union, 19702003, with
a joinpoint analysis, Ann. Oncology, 19, 631 - 640, 2008.
[408] Thompson, I.M., Pauler, D.K., Goodman, P.J. Tangen, C.M., Lucia,
M.S., Parnes, H.L., Minasian, L.M., Ford, L.G., Lippman, S.M.,
Crawford, E.D., Crowley, J.J., and Coltman, C.A., Prevalence of
prostate cancer among men with a prostatespecific antigen level≤4.0
ng per milliliter, N. Engl. J. Med., 350, 2239 - 2246, 2004.
[409] U.S. Preventive Services Task Force Screening for prostate cancer,
U.S. Preventive Services Task Force Recommendation Statement,
Ann. Intern. Med., 149, 185 - 191, 2008.
[410] Lin, K., Lipsitz, R., Miller, T., Janakiraman, S., and U.S. Preventive
Services Task Force, Benefits and harms of prostatespecific antigen
screening for prostate cancer: an evidence update for the U.S.
Preventive Services Task Force, Ann. Intern. Med., 149, 192 - 199,
2008.
[411] Ornstein, D.K., and Kang, J., How to improve prostate biopsy
detection of prostate cancer, Curr. Urology Rep., 2, 218 - 223, 2001.
[412] Mazaheri, Y., ShuklaDave, A., Hricak, H., Fine, S.W., Zhang, J.,
Inurrigarro, G., Moskowitz, C.S., Ishill, N.M., Reuter, V.E., Touijer,
K., Zakian, K.L., and Koutcher, J.A., Prostate cancer: identification
with combined diffusionweighted MR imaging and 3D 1 1H MR
spectroscopic imaging - correlation with pathologic findings,
Radiology, 246, 480 - 488, 2008.
[413] Kurhanewicz, J., Swanson, M.G., Nelson, S.J., and Vigneron, D.B.,
Combined magnetic resonance imaging and spectroscopic imaging
approach to molecular imaging of prostate cancer, J. Magn. Reson.
Imag., 16, 451 - 463, 2002.
[414] Casciani, E., and Gualdi, G.F., Prostate cancer: value of magnetic
resonance spectroscopy 3D chemical shift imaging, Abdom. Imag. 31,
490 - 499, 2006.
[415] Spielman, D., In vivo proton MR spectroscopy: basic principles and
clinical applications, Magn. Section for Magnetic Resonance
Technologists Educational Seminars, 3, 19 - 37, 2000.
[416] Costello, L.C., Franklin, R.B., and Narayan, P., Citrate in the
diagnosis of prostate cancer, Prostate, 38, 237 - 245, 1999.